Berberine and probiotics combo successful in reducing blood sugar level in diabetic patients – China 12-week RCT

By Tingmin Koe contact

- Last updated on GMT

The combined supplementation of berberine and probiotics has shown to reduce blood sugar levels in diabetic patients.  ©Getty Images
The combined supplementation of berberine and probiotics has shown to reduce blood sugar levels in diabetic patients. ©Getty Images

Related tags: Blood sugar management, China, Probiotics, berberine

The combined supplementation of the botanical berberine and probiotics has been found to help reduce blood sugar levels in diabetic patients, more so than taking each product alone, says a 12-week RCT conducted in China.

Published in Nature Communications, ​the findings showed that berberine (BBR) alone or berberine with probiotics is more effective in reducing the amount of glycated haemoglobin as compared to taking probiotics alone.

The trial randomised 409 participants into four groups.

One group took BBR pills plus probiotics powder, the other took BBR pills alone, the third group took probiotics powder alone, and the last group took placebo. 

By the end of the trial, the group which took in berberine and probiotics had greatest reduction in the amount of glycated haemoglobin, HbA1c.

The percentage of HbA1c found in their blood dropped from 7.66 ± 0.82 to 6.62 ± 0.66, which was a 1.04 drop.

The next most effective outcome was seen in the group that took BBR alone, where the percentage of HbA1c fell from 7.68 ± 0.76 to 6.71 ± 0.77, which was a 0.99 decrease.

The groups which took placebo or probiotics did not see significant reduction in their level of HbA1c, since their HbA1c only dropped by 0.59 and 0.53 respectively.

Reasons

The two most effective interventions led to changes in the relative abundance of 78 bacteria species.

For instance, BBR depleted the bacteria species that mainly produce single sugar or short chain fatty acids (SCFAs) that from fermenting polysaccharides or oligosaccharides. These include bacteria such as Roseburia​ spp., Ruminococcus bromii​, Faecalibacterium prausnitzii​ and Bifidobacterium​ spp.

Further metagenomics and metabolomic studies found that the BBR’s blood sugar lowering effect is due to the bacteria ruminococcus bromii – ​which plays a key role in degrading starch.

The bacteria inhibit production of bile acids key in regulating metabolic homeostasis. In this case, it inhibited the production of the deoxycholic acid species (DCAs).

“R. bromii could be the target of BBR in the gut microbiome to reduce the microbial production of secondary bile acid that is associated with the effective glycaemic control achieved with BBR.

“The study thus reports a human microbial related mechanism underlying the anti-diabetic effect of BBR on type II diabetes,”​ the researchers said.

BBR also elevated the bacterial response functions similar to the diabetes treatment medicine metformin, said the researchers.

BBR’s good and bad

On the other hand, the groups which took BBR saw improvements in other metabolic parameters, such as a lower fasting plasma glucose, blood triglycerides, total cholesterol, and low-density lipoprotein cholesterol levels.

Yet, at the same time, the BBR treatment also induced more gastrointestinal side effects.

“More participants experienced gastrointestinal adverse events in the BBR-treated groups than that in the placebo or probiotics groups.

“(However), the adverse events did not affect the antidiabetic effect of BBR or gut microbiome features in this study with a 3-month treatment, again the concern needs to be addressed in trials with longer intervention duration,”​ the researchers said.

Probiotics’ role

Probiotics supplementation played a more significant role in controlling blood sugar level in older participants age 50 and above.

“Our study failed to find significant metabolic improvement with probiotic supplementation in type II diabetic patients, except when it was used in combination with BBR in the older participants.

 “This was consistent with the conclusion from preponderant literatures that probiotics have limited effects in the treatment of metabolic diseases,”​ the researchers said.

However, they also said that such findings could be the result of bacteria strain-specific functional variations, hence the need for a more precise strategy for probiotics treatment.

The study was funded by grants from China’s national research funds, such as the National Key R&D Program of China.

 

Source: Nature Communications

Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)

doi: 10.1038/s41467-020-18414-8

Authors: Yifei Zhang et al 

Related news

Show more

Related products

show more

Physta Tongkat Ali - Transforming Lives

Physta Tongkat Ali - Transforming Lives

Biotropics Malaysia | 08-Dec-2020 | Technical / White Paper

Population ageing has led to consumers' increasing search for natural products with a range of benefits. Physta, a premium Tongkat Ali extract supplied...

LalDéfense 85% yeast beta-glucan

LalDéfense 85% yeast beta-glucan

Lallemand Bio-Ingredients | 12-Nov-2020 | Infographic

LalDéfense is highly purified 85% yeast beta-glucan, suitable to support your natural defenses. Yeast beta-glucan has been extensively studied and proven...

Naturally stable astaxanthin for healthy aging

Naturally stable astaxanthin for healthy aging

Lipofoods, a Lubrizol Company | 16-Oct-2020 | Product Presentation

In this video, the Nutraceuticals Division of Lubrizol Life Science Health presents ASTAGILE™ microcapsules, a natural, stable microencapsulated astaxanthin...

Related suppliers

Follow us

Products

View more

Webinars

Nutra Champions Podcast

Nutra Champions Podcast